Cargando…

The Beta-Amyloid Protein of Alzheimer's Disease: Communication Breakdown by Modifying the Neuronal Cytoskeleton

Alzheimer's disease (AD) is one of the most prevalent severe neurological disorders afflicting our aged population. Cognitive decline, a major symptom exhibited by AD patients, is associated with neuritic dystrophy, a degenerative growth state of neurites. The molecular mechanisms governing neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mokhtar, Sara H., Bakhuraysah, Maha M., Cram, David S., Petratos, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876695/ https://www.ncbi.nlm.nih.gov/pubmed/24416616 http://dx.doi.org/10.1155/2013/910502

Ejemplares similares

Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer's disease
por: Mokhtar, Sara H., et al.
Publicado: (2018)

Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
por: Bakhuraysah, Maha M., et al.
Publicado: (2016)

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
por: Moro, Maria Luisa, et al.
Publicado: (2018)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
por: Ding, Yu, et al.
Publicado: (2019)

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
por: Perez-Garmendia, Roxanna, et al.
Publicado: (2013)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression
por: Alrehaili, Amani A., et al.
Publicado: (2018)

Cytoskeleton Protein EB3 Contributes to Dendritic Spines Enlargement and Enhances Their Resilience to Toxic Effects of Beta-Amyloid
por: Pchitskaya, Ekaterina, et al.
Publicado: (2022)

Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis
por: Litwak, Sara A., et al.
Publicado: (2013)

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease
Publicado: (1993)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
por: Roda, Alejandro R., et al.
Publicado: (2022)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Breakdown of supersaturation barrier links protein folding to amyloid formation
por: Noji, Masahiro, et al.
Publicado: (2021)

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease
por: Zagorski, Karen, et al.
Publicado: (2023)

Truncated and modified amyloid-beta species
por: Kummer, Markus P, et al.
Publicado: (2014)

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
por: Wang, Pei‐Ning, et al.
Publicado: (2020)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
por: Verdile, Giuseppe, et al.
Publicado: (2006)

Neurobiological pathways to Alzheimer’s disease: Amyloid-beta, TAU protein or both?
por: de Paula, Vanessa de Jesus R., et al.
Publicado: (2009)

Dielectrophoresis of Amyloid-Beta Proteins as a Microfluidic Template for Alzheimer’s Research
por: Al-Ahdal, Salman Ali, et al.
Publicado: (2019)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Isolation and chemical characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core protein
Publicado: (1988)

Intracellular Accumulation of Amyloid-Beta – A Predictor for Synaptic Dysfunction and Neuron Loss in Alzheimer's Disease
por: Bayer, Thomas A., et al.
Publicado: (2010)

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
por: Goure, William F, et al.
Publicado: (2014)

Fasting activates macroautophagy in neurons of Alzheimer’s disease mouse model but is insufficient to degrade amyloid-beta
por: Chen, Xigui, et al.
Publicado: (2015)

Alzheimer’s research—breakthrough or breakdown?
por: Spires-Jones, Tara L
Publicado: (2021)

Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease
por: Volloch, Vladimir, et al.
Publicado: (2018)

Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer’s disease pathogenesis
por: Li, Nuo-Min, et al.
Publicado: (2019)

The amyloid beta ion channel hypothesis of Alzheimer’s disease
por: Shirwany, Najeeb A, et al.
Publicado: (2007)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
por: Wildburger, Norelle C., et al.
Publicado: (2017)

Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
por: Sadigh-Eteghad, Saeed, et al.
Publicado: (2015)

The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer’s Disease
por: Hillen, Heinz
Publicado: (2019)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
por: Lee, Joo-Hee, et al.
Publicado: (2021)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
por: Hefner, Marleigh, et al.
Publicado: (2021)

Diagnosed Mild Cognitive Impairment Due to Alzheimer’s Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction
por: Hatashita, Shizuo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_piu0gqi7e9mj1mppo5ih2a2n41